Concepedia

Author

Ayodeji Agboola

Olabisi Onabanjo UniversityORCID

Also Known As

A Agboola, A O Agboola, A O J Agboola, A S Agboola, A. Agboola, A. J. Agboola, A. O. J. Agboola, A.O. J. Agboola, A.O.J. Agboola, ADEDAMOLA AGBOOLA

41

Publications

285

Citations

10

H-Index

17

Concepts

All Affiliations

Olabisi Onabanjo UniversityUniversity of NottinghamNottingham University Hospitals NHS TrustOlabisi Onabanjo University Teaching Hospital
AA

About

Ayodeji Agboola is an author at Olabisi Onabanjo University specializing in medicine, breast cancer, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

150

2

Cell Biology

3

3

62

3

Nursing

2

2

27

4

Health Sciences

1

1

23

5

Family Medicine

1

1

16

Ayodeji Agboola

×

9

Publications

201

Citations

9

H-Index

YearCitations

Molecular characteristics and prognostic features of breast cancer in Nigerian compared with UK women

Ayodeji Agboola, A A Musa, N. Wanangwa,

Breast Cancer Research and Treatment

2012

61

Pattern of childhood malignant tumours in a teaching hospital in south‐western Nigeria

Ayodeji Agboola, Folashade Adekanmbi, Adewale A Musa,

The Medical Journal of Australia

2009

28

EpCAM expression is an indicator of recurrence in basal-like breast cancer

Ayodeji Agboola, Emma C. Paish, Emad A. Rakha,

Breast Cancer Research and Treatment

2011

26

Cell Proliferation (KI-67) Expression Is Associated with Poorer Prognosis in Nigerian Compared to British Breast Cancer Women

Ayodeji Agboola, A A F Banjo, C C Anunobi,

ISRN Oncology

2013

23

Beliefs and practices associated with late presentation in patients with breast cancer; an observational study of patient presenting in a tertiary care facility in Southwest Nigeria

BA Ayoade, B A Salami, Ayodeji Agboola,

Journal africain du cancer / African Journal of Cancer

2015

16

Clinicopathological and molecular significance of Sumolyation marker (ubiquitin conjugating enzyme 9 (UBC9)) expression in breast cancer of black women

Ayodeji Agboola, A A Musa, BA Ayoade,

Pathology - Research and Practice

2013

13

Molecular profiling of breast cancer in Nigerian women identifies an altered p53 pathway as a major mechanism underlying its poor prognosis compared with British counterpart.

Ayodeji Agboola, A A Banjo, C C Anunobi,

PubMed

2014

12

PIASγ expression in relation to clinicopathological, tumour factors and survival in indigenous black breast cancer women

Ayodeji Agboola, Adewale A Musa, A A F Banjo,

Journal of Clinical Pathology

2013

11

Clinical characteristics and survival outcome of breast cancer in southwest Nigerian women

BA Ayoade, Ayodeji Agboola, A. A. Olatunji,

Journal africain du cancer / African Journal of Cancer

2014

11

Page 1